Gene S. Kennedy, M.d., P.C.

Gene S. Kennedy, M.D., P.C., doing business as Kennedy, Gene S Office, is a veteran-owned small business medical practice based in St. Simons Island, Georgia, that provides expert witness and subject matter expert medical consulting services exclusively to the federal government as a prime contractor on purchase orders, with no subcontract footprint and no participation in larger contract vehicles or set-asides.

The practice operates as a for-profit corporate entity and competes in full-and-open procurement without SBA set-aside designations across all 158 recent awards. Dr. Kennedy's capability portfolio is narrow and specialized: Prescription Drug Monitoring Program analysis, medical record and patient file reviews, case consultations, and expert witness testimony in support of controlled substance diversion investigations and pharmaceutical regulatory compliance efforts. Representative work includes a $50.5 thousand purchase order from the Drug Enforcement Administration (DEA) for subject matter expert and expert witness services on controlled substance investigations (awarded March 13, 2026), a $37.25 thousand DEA purchase order for expert witness and medical analysis services related to diversion cases (awarded March 18, 2024), and a $42.5 thousand U.S. Attorney's Offices purchase order for expert medical services and expert witness testimony supporting federal drug-related investigations and prosecutions (awarded August 24, 2023).

Customer concentration is extreme and poses recompete risk. The DEA accounts for 136 of 158 awards (86% of the portfolio) with combined potential value of $1.4 million; the U.S. Attorney's Offices holds 20 awards ($435 thousand), and two additional Department of Justice components (Criminal Division and FBI Mobile Field Office) together represent two awards ($20 thousand). This 100% Department of Justice footprint means Dr. Kennedy operates as a specialized vendor to a single federal customer organization with no geographic or agency diversification. Within the next twenty-four months, thirteen awards carrying combined potential value of $254 thousand reach ultimate completion and face recompete. Performance locations span St. Simons Island and Jacksonville, Florida, plus other locations nationwide to support DEA field divisions and U.S. Attorney's Offices.

Activity has grown modestly year over year—nine awards in 2022 to fifteen in 2025—and remained consistent at nine awards through October 2026 in the current year. All 158 awards are purchase orders structured as labor-hours or time-and-materials arrangements, with no larger parent vehicle participation. The combined potential value of $1.9 million reflects the individual transactional nature of the relationship: purchase orders range from $250 to $57.3 thousand, and 92% of potential value has already been obligated across the portfolio, indicating mature, active invoicing rather than forward pipeline growth. The vendor operates with no identified subcontractors and performs all work directly through Dr. Kennedy's medical expertise.